Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

Scalp psoriasis is an autoimmune condition that may be worsened by poor hygiene but isn’t caused by it A dermatologist ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, but there are also over-the-counter products that can help manage flare-ups ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Pronounced “soh-TIK-too,” SOTYKTU is a once-daily pill for adults with moderate to severe plaque psoriasis that works inside ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

ZORYVE foam allows patients to treat their whole body with one prescription, transforming the treatment landscape for scalp and body psoriasis.” “Individuals living with psoriasis, a chronic ...

Topical psoriasis treatments are applied directly to your ... also find relief from psoriasis itch and dryness with over-the-counter skin-care products containing zinc, aloe, or capsaicin.

The U.S. Food and Drug Administration (FDA) has approved ZORYVE® (roflumilast) topical foam 0.3% for the treatment of plaque ... and promising second-quarter prescription trends.

Arcutis Biotherapeutics has published 14 consensus statements developed by the Genital Psoriasis Wellness Consortium ... commercial drug insurance or whose prescription claims are eligible ...